 | • レポートコード：20QY06-00867 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、インスリングラルギンのグローバル市場について種類別（単回バイアル、プレフィルドシリンジ）、用途別（2型糖尿病治療、1型糖尿病治療）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・インスリングラルギン市場の概要 ・世界の主要地域別インスリングラルギン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のインスリングラルギン市場規模2015-2026：種類別（単回バイアル、プレフィルドシリンジ） ・世界のインスリングラルギン市場規模2015-2026：用途別（2型糖尿病治療、1型糖尿病治療） ・インスリングラルギンの北米市場規模2015-2020 ・インスリングラルギンのヨーロッパ市場規模2015-2020 ・インスリングラルギンの中国市場規模2015-2020 ・インスリングラルギンの日本市場規模2015-2020 ・インスリングラルギンの東南アジア市場規模2015-2020 ・インスリングラルギンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi-Aventis、Ganlee、Biocon） ・インスリングラルギンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インスリングラルギンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Insulin Glargine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Insulin Glargine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a “peakless” profile (according to the insulin glargine package insert).
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Insulin Glargine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Insulin Glargine industry.
Based on our recent survey, we have several different scenarios about the Insulin Glargine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 6174.3 million in 2019. The market size of Insulin Glargine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Insulin Glargine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Insulin Glargine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Insulin Glargine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Insulin Glargine market. The report also includes nautical information, where it shows Insulin Glargine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Insulin Glargine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Insulin Glargine market.
Insulin glargine is a long-acting, man-made version of human insulin. Insulin glargine works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is Used for energy. It also stops the liver from producing more sugar.
There are two type of Insulin glargine, which are Single Dose Vial and Pre-filled Syringe in the market. Considering its function, Insulin glargine is Used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also Used to treat people with type 2 diabetes (condition in which the body does not Used insulin normally and, therefore, cannot control the amount of sugar in the blood) who need insulin to control their diabetes.
We can see that there are just a few companies produce Insulin glargine, the production of them almost approach to 70% of whole market. They have seted plant in Japan, China, German, India, North Americato produce Insulin glargine, and China is the largest plant for Insulin glargine in the world and also the largest consumption country. As the amount of diabetes of increasing of China, the Chinese market will be bigger than North America.
The Industry is affected by the economic development level and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to care about personal health, especially in underdevelopment regions that have a large population and fast economic growth, the need of Insulin glargine will increase.
Geographical Analysis:
Based on region, the global Insulin Glargine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Insulin Glargine market are
Sanofi-Aventis
Ganlee
Biocon
…
Segment by Type
Single Dose Vial
Pre-filled Syringe
Segment by Application
Treat type2 diabetes
Treat type1 diabetes
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Insulin Glargine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Insulin Glargine market.
• The market share of the global Insulin Glargine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Insulin Glargine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Insulin Glargine market.
1 Insulin Glargine Market Overview
1.1 Insulin Glargine Product Scope
1.2 Insulin Glargine Segment by Type
1.2.1 Global Insulin Glargine Sales by Type (2020-2026)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Insulin Glargine Segment by Application
1.3.1 Global Insulin Glargine Sales Comparison by Application (2020-2026)
1.3.2 Treat type2 diabetes
1.3.3 Treat type1 diabetes
1.4 Insulin Glargine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Insulin Glargine Sales Growth Rate (2015-2026)
1.4.2 Global Insulin Glargine Revenue and Growth Rate (2015-2026)
1.4.3 Global Insulin Glargine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Insulin Glargine Industry Impact
1.5.1 How the Covid-19 is Affecting the Insulin Glargine Industry
1.5.1.1 Insulin Glargine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Insulin Glargine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Insulin Glargine Players to Combat Covid-19 Impact
2 Insulin Glargine Estimate and Forecast by Region
2.1 Global Insulin Glargine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Insulin Glargine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Insulin Glargine Sales Market Share by Region (2015-2020)
2.2.2 Global Insulin Glargine Revenue Market Share by Region (2015-2020)
2.3 Global Insulin Glargine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Insulin Glargine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Insulin Glargine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Insulin Glargine Estimates and Projections (2015-2026)
2.4.2 Europe Insulin Glargine Estimates and Projections (2015-2026)
2.4.3 China Insulin Glargine Estimates and Projections (2015-2026)
2.4.4 Japan Insulin Glargine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Insulin Glargine Estimates and Projections (2015-2026)
2.4.6 India Insulin Glargine Estimates and Projections (2015-2026)
3 Global Insulin Glargine Competition Landscape by Players
3.1 Global Top Insulin Glargine Players by Sales (2015-2020)
3.2 Global Top Insulin Glargine Players by Revenue (2015-2020)
3.3 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Glargine as of 2019)
3.4 Global Insulin Glargine Average Price by Company (2015-2020)
3.5 Manufacturers Insulin Glargine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Insulin Glargine Players (Opinion Leaders)
4 Global Insulin Glargine Market Size by Type
4.1 Global Insulin Glargine Historic Market Review by Type (2015-2020)
4.1.1 Global Insulin Glargine Sales Market Share by Type (2015-2020)
4.1.2 Global Insulin Glargine Revenue Market Share by Type (2015-2020)
4.1.3 Global Insulin Glargine Price by Type (2014-2020)
4.2 Global Insulin Glargine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Insulin Glargine Sales Forecast by Type (2021-2026)
4.2.2 Global Insulin Glargine Revenue Forecast by Type (2021-2026)
4.2.3 Global Insulin Glargine Price Forecast by Type (2021-2026)
5 Global Insulin Glargine Market Size by Application
5.1 Global Insulin Glargine Historic Market Review by Application (2015-2020)
5.1.1 Global Insulin Glargine Sales Market Share by Application (2015-2020)
5.1.2 Global Insulin Glargine Revenue Market Share by Application (2015-2020)
5.1.3 Global Insulin Glargine Price by Application (2015-2020)
5.2 Global Insulin Glargine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Insulin Glargine Sales Forecast by Application (2021-2026)
5.2.2 Global Insulin Glargine Revenue Forecast by Application (2021-2026)
5.2.3 Global Insulin Glargine Price Forecast by Application (2021-2026)
3 North America Insulin Glargine Market Facts & Figures
3.2 North America Insulin Glargine Sales Market Share by Company (2015-2020)
3.3 North America Insulin Glargine Sales Market Share by Type (2015-2020)
3.4 North America Insulin Glargine Sales Market Share by Application (2015-2020)
4 Europe Insulin Glargine Market Facts & Figures
4.2 Europe Insulin Glargine Sales Market Share by Company (2015-2020)
4.3 Europe Insulin Glargine Sales Market Share by Type (2015-2020)
4.4 Europe Insulin Glargine Sales Market Share by Application (2015-2020)
5 China Insulin Glargine Market Facts & Figures
5.2 China Insulin Glargine Sales Market Share by Company (2015-2020)
5.3 China Insulin Glargine Sales Market Share by Type (2015-2020)
5.4 China Insulin Glargine Sales Market Share by Application (2015-2020)
6 Japan Insulin Glargine Market Facts & Figures
6.2 Japan Insulin Glargine Sales Market Share by Company (2015-2020)
6.3 Japan Insulin Glargine Sales Market Share by Type (2015-2020)
6.4 Japan Insulin Glargine Sales Market Share by Application (2015-2020)
7 Southeast Asia Insulin Glargine Market Facts & Figures
7.2 Southeast Asia Insulin Glargine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Insulin Glargine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Insulin Glargine Sales Market Share by Application (2015-2020)
8 India Insulin Glargine Market Facts & Figures
8.2 India Insulin Glargine Sales Market Share by Company (2015-2020)
8.3 India Insulin Glargine Sales Market Share by Type (2015-2020)
8.4 India Insulin Glargine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Insulin Glargine Business
12.1 Sanofi-Aventis
12.1.1 Sanofi-Aventis Insulin Glargine Corporation Information
12.1.2 Sanofi-Aventis Insulin Glargine Business Overview and Total Revenue
12.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi-Aventis Insulin Glargine Products Offered
12.1.5 Sanofi-Aventis Recent Development
12.2 Ganlee
12.2.1 Ganlee Insulin Glargine Corporation Information
12.2.2 Ganlee Insulin Glargine Business Overview and Total Revenue
12.2.3 Ganlee Insulin Glargine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Ganlee Insulin Glargine Products Offered
12.2.5 Ganlee Recent Development
12.3 Biocon
12.3.1 Biocon Insulin Glargine Corporation Information
12.3.2 Biocon Insulin Glargine Business Overview and Total Revenue
12.3.3 Biocon Insulin Glargine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Biocon Insulin Glargine Products Offered
12.3.5 Biocon Recent Development
…
13 Insulin Glargine Manufacturing Cost Analysis
13.1 Insulin Glargine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Insulin Glargine
13.4 Insulin Glargine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Insulin Glargine Distributors List
14.3 Insulin Glargine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Insulin Glargine Sales (M mL) Growth Rate by Type (2020-2026)
Table 2. Global Insulin Glargine Sales (M mL) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Insulin Glargine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Insulin Glargine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Insulin Glargine Players to Combat Covid-19 Impact
Table 8. Global Market Insulin Glargine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Insulin Glargine Sales (M mL) by Region (2015-2020)
Table 10. Global Insulin Glargine Sales Market Share by Region (2015-2020)
Table 11. Global Insulin Glargine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Insulin Glargine Revenue Share by Region (2015-2020)
Table 13. Global Insulin Glargine Sales (M mL) Forecast by Region (2021-2026)
Table 14. Global Insulin Glargine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Insulin Glargine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Insulin Glargine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Insulin Glargine (M mL) of Key Companies (2015-2020)
Table 18. Global Insulin Glargine Sales Share by Company (2015-2020)
Table 19. Global Insulin Glargine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Insulin Glargine Revenue Share by Company (2015-2020)
Table 21. Global Insulin Glargine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Glargine as of 2019)
Table 22. Global Insulin Glargine Average Price (USD/mL) of Key Company (2015-2020)
Table 23. Manufacturers Insulin Glargine Manufacturing Sites and Area Served
Table 24. Manufacturers Insulin Glargine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Insulin Glargine Players
Table 27. Global Insulin Glargine Sales (M mL) by Type (2015-2020)
Table 28. Global Insulin Glargine Sales Share by Type (2015-2020)
Table 29. Global Insulin Glargine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Insulin Glargine Price (M mL) by Type (2015-2020)
Table 31. Global Insulin Glargine Sales Share by Type (2021-2026)
Table 32. Global Insulin Glargine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Insulin Glargine Revenue Share by Type (2021-2026)
Table 34. Global Insulin Glargine Price (M mL) by Type (2021-2026)
Table 35. Global Insulin Glargine Sales (M mL) by Application (2015-2020)
Table 36. Global Insulin Glargine Sales Share by Application (2015-2020)
Table 37. Global Insulin Glargine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Insulin Glargine Price (M mL) by Application (2015-2020)
Table 39. Global Insulin Glargine Sales (M mL) by Application (2021-2026)
Table 40. Global Insulin Glargine Sales Share by Application (2021-2026)
Table 41. Global Insulin Glargine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Insulin Glargine Revenue Share by Application (2021-2026)
Table 43. Global Insulin Glargine Price (M mL) by Application (2021-2026)
Table 44. United States Insulin Glargine Sales (M mL) by Company (2015-2020)
Table 45. United States Insulin Glargine Sales Market Share by Company (2015-2020)
Table 46. United States Insulin Glargine Sales (M mL) by Type (2015-2020)
Table 47. United States Insulin Glargine Sales Market Share by Type (2015-2020)
Table 48. United States Insulin Glargine Sales (M mL) by Application (2015-2020)
Table 49. United States Insulin Glargine Sales Market Share by Application (2015-2020)
Table 50. Europe Insulin Glargine Sales (M mL) by Company (2015-2020)
Table 51. Europe Insulin Glargine Sales Market Share by Company (2015-2020)
Table 52. Europe Insulin Glargine Sales (M mL) by Type (2015-2020)
Table 53. Europe Insulin Glargine Sales Market Share by Type (2015-2020)
Table 54. Europe Insulin Glargine Sales (M mL) by Application (2015-2020)
Table 55. Europe Insulin Glargine Sales Market Share by Type (2015-2020)
Table 56. China Insulin Glargine Sales (M mL) by Company (2015-2020)
Table 57. China Insulin Glargine Sales Market Share by Company (2015-2020)
Table 58. China Insulin Glargine Sales (M mL) by Type (2015-2020)
Table 59. China Insulin Glargine Sales Market Share by Type (2015-2020)
Table 60. China Insulin Glargine Sales (M mL) by Application (2015-2020)
Table 61. China Insulin Glargine Sales Market Share by Application (2015-2020)
Table 62. Japan Insulin Glargine Sales (M mL) by Company (2015-2020)
Table 63. Japan Insulin Glargine Sales Market Share by Company (2015-2020)
Table 64. Japan Insulin Glargine Sales (M mL) by Type (2015-2020)
Table 65. Japan Insulin Glargine Sales Market Share by Type (2015-2020)
Table 66. Japan Insulin Glargine Sales (M mL) by Application (2015-2020)
Table 67. Japan Insulin Glargine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Insulin Glargine Sales (M mL) by Company (2015-2020)
Table 69. Southeast Asia Insulin Glargine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Insulin Glargine Sales (M mL) by Type (2015-2020)
Table 71. Southeast Asia Insulin Glargine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Insulin Glargine Sales (M mL) by Type (2015-2020)
Table 73. Southeast Asia Insulin Glargine Sales Market Share by Application (2015-2020)
Table 74. India Insulin Glargine Sales (M mL) by Company (2015-2020)
Table 75. India Insulin Glargine Sales Market Share by Company (2015-2020)
Table 76. India Insulin Glargine Sales (M mL) by Type (2015-2020)
Table 77. India Insulin Glargine Sales Market Share by Type (2015-2020)
Table 78. India Insulin Glargine Sales (M mL) by Application (2015-2020)
Table 79. India Insulin Glargine Sales Market Share by Application (2015-2020)
Table 80. Sanofi-Aventis Corporation Information
Table 81. Sanofi-Aventis Description and Business Overview
Table 82. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2015-2020)
Table 83. Sanofi-Aventis Insulin Glargine Product
Table 84. Sanofi-Aventis Recent Development
Table 85. Ganlee Corporation Information
Table 86. Ganlee Description and Business Overview
Table 87. Ganlee Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2015-2020)
Table 88. Ganlee Insulin Glargine Product
Table 89. Ganlee Recent Development
Table . Biocon Corporation Information
Table . Biocon Description and Business Overview
Table . Biocon Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2015-2020)
Table . Biocon Insulin Glargine Product
Table . Biocon Recent Development
Table 95. Production Base and Market Concentration Rate of Raw Material
Table 96. Key Suppliers of Raw Materials
Table 97. Insulin Glargine Distributors List
Table 98. Insulin Glargine Customers List
Table 99. Market Key Trends
Table 100. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 101. Key Challenges
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Glargine Product Picture
Figure 2. Global Insulin Glargine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Insulin Glargine Market Share by Application in 2020 & 2026
Figure 6. Treat type2 diabetes Examples
Figure 7. Treat type1 diabetes Examples
Figure 8. Global Insulin Glargine Sales (M mL) Growth Rate (2015-2026)
Figure 9. Global Insulin Glargine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Insulin Glargine Price Trends Growth Rate (2015-2026) (USD/mL)
Figure 11. Global Insulin Glargine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Insulin Glargine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Insulin Glargine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Insulin Glargine Sales (M mL) Growth Rate (2015-2026)
Figure 15. Europe Insulin Glargine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Insulin Glargine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Insulin Glargine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Insulin Glargine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Insulin Glargine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Insulin Glargine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Insulin Glargine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Insulin Glargine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Insulin Glargine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Insulin Glargine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Insulin Glargine Players Market Share by Revenue in Insulin Glargine 2015 & 2019
Figure 26. Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Insulin Glargine Revenue Share by Type (2015-2020)
Figure 28. Global Insulin Glargine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Insulin Glargine Revenue Share by Application (2015-2020)
Figure 30. Global Insulin Glargine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Insulin Glargine Sales Market Share by Type in 2019
Figure 32. United States Insulin Glargine Sales Market Share by Type in 2019
Figure 33. Europe Insulin Glargine Sales Market Share by Company in 2019
Figure 34. Europe Insulin Glargine Sales Market Share by Type in 2019
Figure 35. Europe Insulin Glargine Sales Market Share by Application in 2019
Figure 36. China Insulin Glargine Sales Market Share by Company in 2019
Figure 37. China Insulin Glargine Sales Market Share by Type in 2019
Figure 38. China Insulin Glargine Sales Market Share by Application in 2019
Figure 39. Japan Insulin Glargine Sales Market Share by Company in 2019
Figure 40. Japan Insulin Glargine Sales Market Share by Type in 2019
Figure 41. Japan Insulin Glargine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Insulin Glargine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Insulin Glargine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Insulin Glargine Sales Market Share by Application in 2019
Figure 45. India Insulin Glargine Sales Market Share by Company in 2019
Figure 46. India Insulin Glargine Sales Market Share by Type in 2019
Figure 47. India Insulin Glargine Sales Market Share by Application in 2019
Figure 48. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Ganlee Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Insulin Glargine
Figure 53. Manufacturing Process Analysis of Insulin Glargine
Figure 54. Insulin Glargine Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
糖尿病インスリンペンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diabetes Insulin Pen market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetes Insulin Pen mar…- インスリンリスプロの世界市場レポート2020 Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is made by reversing the amino acids lysine and proline i…
- インスリンポンプ付属品の世界市場レポート2020 Market Analysis and Insights: Global Insulin pump Accessories Market The global Insulin pump Accessories market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Insulin pump Accessories Scope and Market Size The …
- インスリンAPIの世界市場レポート2020 A recently published report by QY Research titled Global Insulin API Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data i…
- インスリン様成長因子の世界市場レポート2020 Market Analysis and Insights: Global Insulin Like Growth Factor Market The global Insulin Like Growth Factor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Insulin Like Growth Factor Scope and Market Siz…